<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Orthopedics Oncology - QuizMaster Pro</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}


    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / qBank / Orthopedics
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">37</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 489,
    "choices": [
      {
        "id": 1952,
        "text": "<p><span style=\"font-size:12.0pt;\">Osteoid osteoma</span></p>"
      },
      {
        "id": 1953,
        "text": "<p><span style=\"font-size:12.0pt;\">Multiple myeloma</span></p>"
      },
      {
        "id": 1954,
        "text": "<p><span style=\"font-size:12.0pt;\">Eosinophilic granuloma</span></p>"
      },
      {
        "id": 1955,
        "text": "<p><span style=\"font-size:12.0pt;\">Chondromyxoid fibroma</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Moth eaten bone is seen in:</span></p>",
    "unique_key": "Q4431788",
    "question_audio": null,
    "question_video": null,
    "map_id": 514,
    "difficulty_level": "intermediate",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Multiple myeloma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>MULTIPLE MYELOMA</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Radiographically, multiple myeloma appears as multiple, <strong>\u201cpunched-out\u201d, sharply demarcated, purely lytic lesions</strong> without any surrounding reactive sclerosis.</span></li><li><span style=\"font-size:12.0pt;\">Permeative or moth-eaten appearance of bone appears as multiple endosteal lucent lesions with a poor zone of transition. It is due to bone marrow involvement.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture36.jpg\" alt=\"\" width=\"500\" height=\"228\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The lack of reactive bone formation also is shown by the fact that most lesions are negative on bone scan.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Osteoid osteoma.&nbsp;</strong>Plain radiograph may be normal or may show a <strong>solid&nbsp;periosteal reaction</strong>&nbsp;with cortical thickening. The <strong>nidus</strong> can be sometimes visible as a well-circumscribed lucent region, occasionally with a central sclerotic dot. However, dense sclerosis may sometimes obscure the nidus.&nbsp;</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture37.jpg\" alt=\"\" width=\"500\" height=\"554\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Eosinophilic granuloma</strong>. The radiographic features vary considerably, depending on the site of the lesion. In the skull, a <strong>round to oval osteolytic lesion</strong> is seen. The lesion have sharp borders, with a <strong>punched-out appearance</strong>. In the spine, the <strong>thoracic vertebrae</strong> are involved most often (54%), followed by lumbar (35%) and cervical (1 1%) vertebrae. The body of the vertebra is affected; the <strong>posterior elements</strong> are usually <strong>spared</strong>. Fractures of the vertebral bodies may cause marked compression, resulting in the characteristic <strong>vertebra plana</strong> or <strong>silver-coin appearance</strong>. The <strong>diaphysis</strong> is the most common region involved in the long bones.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture38.jpg\" alt=\"\" width=\"300\" height=\"270\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Chodromyxoid fibroma.&nbsp;</strong>Plain radiograph may show lobulated or oval eccentric lytic lesion, well-defined sclerotic margin, often expansile, with long axis parallel to long axis of long bone, <strong>no periosteal reaction</strong> (unless a complicating fracture present), <strong>geographic bone destruction</strong>, and presence of <strong>septations</strong> (pseudotrabeculation).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture39.jpg\" alt=\"\" width=\"500\" height=\"255\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Moth-eaten bone is seen in radiographic image of multiple myeloma.</span></li></ul>",
    "correct_choice_id": 1953,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ]
  },
  {
    "id": 494,
    "choices": [
      {
        "id": 1972,
        "text": "<p><span style=\"font-size:12.0pt;\">SYT-SSX</span></p>"
      },
      {
        "id": 1973,
        "text": "<p><span style=\"font-size:12.0pt;\">MIC 2</span></p>"
      },
      {
        "id": 1974,
        "text": "<p><span style=\"font-size:12.0pt;\">RAS</span></p>"
      },
      {
        "id": 1975,
        "text": "<p><span style=\"font-size:12.0pt;\">P53</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">In Synovial sarcoma, gene affected is:</span></p>",
    "unique_key": "Q7708105",
    "question_audio": null,
    "question_video": null,
    "map_id": 519,
    "difficulty_level": "beginner",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) SYT-SSX</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>SYNOVIAL CELL SARCOMA</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Synovial cell sarcoma (previously called \u2018<strong>synovioma'</strong>) is an uncommon malignant mesenchymal neoplasm comprising 8-10% of soft tissue sarcomas.</span></li><li><span style=\"font-size:12.0pt;\">The term \u2018synovial cell sarcoma' is however a misnomer <strong>as synovial cell sarcomas do not arise from synovium.</strong></span></li><li><span style=\"font-size:12.0pt;\">The term was designated because the <strong>histological appearance of cells from synovial sarcoma resembles normal synovial tissue</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Etiology:</strong></span><ul><li><span style=\"font-size:12.0pt;\">Most synovial sarcomas are associated with a characteristic translocation involving <strong>chromosome X and chromosome 18 i.e., t(X; 18)</strong> giving rise to <strong>SYT-</strong> <strong>SSX fusion genes</strong>.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. MIC 2</strong>. MIC 2 gene is a specific marker for Ewing\u2019s sarcoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. RAS</strong>. This gene is affected in pancreatic, lung and colorectal cancers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. P53</strong>. This gene is affected in breast, colorectal, liver, lung and ovarian cancers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In synovial cell carcinoma, SYT-SSX gene is affected.</span></p>",
    "correct_choice_id": 1972,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 491,
    "choices": [
      {
        "id": 1960,
        "text": "<p><span style=\"font-size:12.0pt;\">Serum acid phosphatase</span></p>"
      },
      {
        "id": 1961,
        "text": "<p><span style=\"font-size:12.0pt;\">CT head with contrast</span></p>"
      },
      {
        "id": 1962,
        "text": "<p><span style=\"font-size:12.0pt;\">Whole body scan</span></p>"
      },
      {
        "id": 1963,
        "text": "<p><span style=\"font-size:12.0pt;\">Serum electrophoresis</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient presented with pain in back. Lab investigation shows elevated ESR. X-ray skull shows multiple punched out lytic lesions. Most important Investigation to be done is:</span></p>",
    "unique_key": "Q8176383",
    "question_audio": null,
    "question_video": null,
    "map_id": 516,
    "difficulty_level": "intermediate",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Serum electrophoresis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>This patient has:</strong></span><ul><li><span style=\"font-size:12.0pt;\">Multiple <strong>punched out lytic lesions</strong> of skull</span></li><li><span style=\"font-size:12.0pt;\">Elevated ESR</span></li><li><span style=\"font-size:12.0pt;\">Back pain</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Diagnosis is multiple myeloma.</span></li><li><span style=\"font-size:12.0pt;\">Multiple myeloma is diagnosed by M bands on serum electrophoresis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Punched out lesions of skull are seen both in Eosinophilic granuloma and multiple myeloma</strong>.</span></li><li><span style=\"font-size:12.0pt;\">However, bevelled edges (double contour) is characteristic of eosinophilic granuloma due to uneven destruction of the inner and outer table of the skull.</span><ul><li><span style=\"font-size:12.0pt;\"><strong>Punched out lesions of skull</strong> \u2013 Multiple myeloma</span></li><li><span style=\"font-size:12.0pt;\"><strong>Punched out lesions with bevelled edges</strong> \u2013 Eosinophilic granuloma</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Serum acid phosphatase</strong>. Serum phosphatase levels are lower or normal in multiple myeloma. So, it cannot be used as a sole diagnostic marker for multiple myeloma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. CT head with contrast</strong>. The role of radiological imaging in multiple myeloma is essential in the initial staging of the disease, in the detection and characterisation of complications, and in the evaluation of patient's response to treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Whole body scan</strong>. Whole-body MRI is the most sensitive technique for detecting bone involvement and assessing painful complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational objective</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The investigation of choice for the patient with pain in back, elevated ESR, and multiple punched out lytic lesions on skull x-ray is serum electrophoresis, which shows monoclonal gammopathy, confirming the diagnosis as multiple myeloma.</span></li></ul>",
    "correct_choice_id": 1963,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 447,
    "choices": [
      {
        "id": 1784,
        "text": "<p><span style=\"font-size:12.0pt;\">Chondrosarcoma</span></p>"
      },
      {
        "id": 1785,
        "text": "<p><span style=\"font-size:12.0pt;\">Osteoclastoma</span></p>"
      },
      {
        "id": 1786,
        "text": "<p><span style=\"font-size:12.0pt;\">Osteogenic sarcoma</span></p>"
      },
      {
        "id": 1787,
        "text": "<p><span style=\"font-size:12.0pt;\">Osteoid sarcoma</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">What is the most likely diagnosis of the X-ray depicted below?</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/08/gct.jpg\" alt=\"\" width=\"250\" height=\"333\"></p>",
    "unique_key": "Q6239481",
    "question_audio": null,
    "question_video": null,
    "map_id": 472,
    "difficulty_level": "beginner",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Osteoclastoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>GIANT CELL TUMOR (OSTEOCLASTOMA)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">They typically occur in patients <strong>20-40 years old</strong>, and there is a slight <strong>female predominance</strong>.</span></li><li><span style=\"font-size:12.0pt;\">The most common location for this tumor is the distal femur, followed closely by the proximal tibia.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Tumor of lower end radius is GCT till proved otherwise.</strong></span></li><li><span style=\"font-size:12.0pt;\">Radiographic findings often are diagnostic.</span></li><li><span style=\"font-size:12.0pt;\">The lesions are eccentrically located in the epiphyses of long bones and usually about the subchondral bone.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture17.jpg\" alt=\"\" width=\"500\" height=\"241\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Microscopically, giant cell tumors are composed of many multinucleated giant cells (typically 40-60 nuclei per cell) in a sea of mononuclear stromal cells (malignant cells).</span></li><li><span style=\"font-size:12.0pt;\"><strong>The nuclei of the mononuclear cells are identical to the nuclei of the giant cells</strong>, a feature that helps to distinguish giant cell tumors from other tumors that may contain many giant cells.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Treatment options:</strong></span><ul><li><span style=\"font-size:12.0pt;\"><strong>Extended Curettage&nbsp;</strong>by PMMA or phenol or liquid nitrogen and <strong>bone grafting</strong> \u2013 procedure of choice for most lesions</span></li><li><span style=\"font-size:12.0pt;\">Excision of lower end of ulna, upper end of fibula</span></li><li><span style=\"font-size:12.0pt;\">Excision and replacement by vascularized bone graft \u2013 lower end of radius where upper end of fibula is grafted</span></li><li><span style=\"font-size:12.0pt;\">Excision and arthrodesis or prosthetic replacement or Turn-O-Plasty (Bone ends are cut and rotated) \u2013 lower end femur and upper end tibia</span></li><li><span style=\"font-size:12.0pt;\">Amputation</span></li><li><span style=\"font-size:12.0pt;\">Malignant recurrent GCT \u2013 Radiotherapy</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Chondrosarcoma.&nbsp;</strong>It peaks between 40 and 60 years for primary chondrosarcoma and between 25 and 45 years for secondary chondrosarcoma. Chondrosarcoma can occur in any location; however, most are located in a proximal location such as the <strong>pelvis (most common site)</strong>, proximal femur, and proximal humerus. <strong>Although chondrosarcomas rarely occur in the hand, they are the most common malignant tumor of bone in this location. </strong>The radiographic appearance of chondrosarcoma lesion arising in the medullary cavity with irregular matrix calcification. The pattern of calcification has been described as \u201c<strong>punctate</strong>\u201d, \u201c<strong>popcorn</strong>\u201d, or \u201c<strong>comma-shaped</strong>\u201d. Chondrosarcoma has a more aggressive appearance with bone destruction, cortical erosions, periosteal reaction, and rarely a soft-tissue mass.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture40.jpg\" alt=\"\" width=\"500\" height=\"297\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Osteogenic sarcoma.&nbsp;</strong>Osteosarcoma is a tumor <strong>characterized by the production of osteoid matrix by malignant cells. </strong>It is the second most common primary malignancy of bone behind multiple myeloma. Onset can occur at any age; however, primary osteosarcoma occurs most commonly in the <strong>second decade of life. </strong>All skeletal locations can be affected; however, most primary osteosarcomas occur at the sites of the most rapid bone growth, including the distal femur, the proximal tibia, and the proximal humerus. Typical radiographic appearances include medullary and cortical bone destruction, permeative&nbsp;or moth-eaten appearance, aggressive&nbsp;periosteal reaction, sunburst&nbsp;appearance, Codman triangle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture19.jpg\" alt=\"\" width=\"300\" height=\"211\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Codman\u2019s triangle</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Osteoid sarcoma</strong>. Osteoid osteoma accounts for 10% of all benign bone tumors.&nbsp;It is neither locally aggressive nor&nbsp;does it have the potential for malignant transformation.&nbsp;This bone tumor frequently affects the long bones of the <strong>femur </strong>and <strong>tibia</strong>. It presents with a <strong>nidus </strong>of vascular osteoid with surrounding sclerotic bone. Osteoid osteomas in long bones are predominantly intracortical.&nbsp;Plain radiograph may be normal or may show a s<strong>olid&nbsp;periosteal reaction</strong>&nbsp;with cortical thickening. The nidus is sometimes visible as a well-circumscribed lucent region, occasionally with a central sclerotic dot. However, dense sclerosis may sometimes obscure the nidus.&nbsp;</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture20.jpg\" alt=\"\" width=\"500\" height=\"531\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The shown x-ray image is characteristic of osteoclastoma or GCT of the distal end of the radius.</span></li></ul>",
    "correct_choice_id": 1785,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 496,
    "choices": [
      {
        "id": 1980,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4</span></p>"
      },
      {
        "id": 1981,
        "text": "<p><span style=\"font-size:12.0pt;\">2, 3, 1</span></p>"
      },
      {
        "id": 1982,
        "text": "<p><span style=\"font-size:12.0pt;\">2, 3, 5</span></p>"
      },
      {
        "id": 1983,
        "text": "<p><span style=\"font-size:12.0pt;\">2, 3, 4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">True about Bone metastasis are:&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">5% bone metastasis are symptomatic</span></li><li><span style=\"font-size:12.0pt;\">Higher serum levels of alkaline phosphatase</span></li><li><span style=\"font-size:12.0pt;\">Most common secondary in female is breast</span></li><li><span style=\"font-size:12.0pt;\">Prostate produce osteosclerotic lesion</span></li><li><span style=\"font-size:12.0pt;\">Commonly involves hand and feet bones</span></li></ol>",
    "unique_key": "Q7858885",
    "question_audio": null,
    "question_video": null,
    "map_id": 521,
    "difficulty_level": "intermediate",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 2, 3, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Most common tumor producing bone metastasis in females is breast carcinoma and in males is prostatic carcinoma.</span></li><li><span style=\"font-size:12.0pt;\">Prostatic carcinoma produces <strong>osteoblastic (osteosclerotic) lesions</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Osteoblastic lesions are associated with <strong>higher serum levels of alkaline phosphatase</strong> (reflecting high activity of osteoblasts).</span></li><li><span style=\"font-size:12.0pt;\">Metastases below elbow and knee are rare.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Most of the patients (about 75%) with bone metastasis presents with a common symptom of pain.</span></li><li><span style=\"font-size:12.0pt;\">Patients with solid cancer and bone lesions have a higher mean level of ALP compared with Multiple Myeloma while the lowest levels of ALP can be found in patients with bone metastatic kidney cancer.</span></li><li><span style=\"font-size:12.0pt;\">Breast cancer and prostate cancer are the most common cause of bone metastasis.</span></li><li><span style=\"font-size:12.0pt;\">Lower extremities, pelvis and vertebrae are more commonly involved in bone metastasis.</span></li></ul>",
    "correct_choice_id": 1983,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 490,
    "choices": [
      {
        "id": 1956,
        "text": "<p><span style=\"font-size:12.0pt;\">Multiple myeloma</span></p>"
      },
      {
        "id": 1957,
        "text": "<p><span style=\"font-size:12.0pt;\">Hairy cell leukemia</span></p>"
      },
      {
        "id": 1958,
        "text": "<p><span style=\"font-size:12.0pt;\">Plasma cellleukemia</span></p>"
      },
      {
        "id": 1959,
        "text": "<p><span style=\"font-size:12.0pt;\">Metastasis periosteal</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 70-year-old male complains of multiple bone pains. On evaluation, he has high ESR, high Calcium values, lytic lesion in multiple bones, and &gt;20% plasma cells in peripheral smear. Most likely diagnosis is:</span></p>",
    "unique_key": "Q4763717",
    "question_audio": null,
    "question_video": null,
    "map_id": 515,
    "difficulty_level": "difficult",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Plasma cell leukemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>More than 20% plasma cells in PS \u2013 </strong>Plasma cell leukemia</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>PLASMA CELL LEUKEMIA</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Plasma cell leukemia (PCL) is a rare, and <strong>aggressive form of multiple myeloma</strong> (MM) characterized by plasma cells circulating in the peripheral blood that can be detected on conventional peripheral blood smear examination.</span></li><li><span style=\"font-size:12.0pt;\">PCL can either originate <strong>de novo</strong> (primary PCL) or as a <strong>secondary</strong> leukemic transformation of MM (secondary PCL).</span></li><li><span style=\"font-size:12.0pt;\">Primary PCL is more common in <strong>younger</strong> patients accompanied by hepatomegaly, splenomegaly, extramedullary disease, renal failure, hypercalcemia, thrombocytopenia, increased LDH levels.</span></li><li><span style=\"font-size:12.0pt;\">The <strong>del(17p), t(11;14), and t(14;16)</strong> are common in primary PCL patients.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Chromosome 1</strong> abnormalities are more common in PCL than in MM and are more frequent in secondary PCL than in primary PCL.</span></li><li><span style=\"font-size:12.0pt;\">According to a recent study, <strong>TP53 mutations</strong> are significantly more common in primary PCL than in MM patients.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\"><strong>Elevated lactate dehydrogenase</strong> (LDH) is common.</span></li><li><span style=\"font-size:12.0pt;\">Most patients present with <strong>cytopenia</strong> and <strong>extramedullary involvement</strong> of the liver, spleen, and other organs besides the blood.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Multiple myeloma</strong>. Diagnosis of MM is made if plasmacytosis (&gt;10%) is present with either&nbsp; lytic bone lesion, serum or urine M component, progressive increase in M component over time or extramedullary mass lesion development.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hairy cell leukemia</strong>. The hairy cell has characteristic-appearing mononuclear cells which are typically large with circumferential hair-like cytoplasmic projections and a round, well-defined nucleus. The flow cytometry markers positive in hairy cell leukemia include CD11c, CD25, CD103, and CD123, along with typical B-cell markers such as CD19, CD20, or CD22. The cyclin-d1 expression is usually present, but it is weak or focal. HCL-V is negative for CD25 and CD123.&nbsp;<i>BRAF</i>-mutation V600E is seen in nearly all cases of classic hairy cell leukemia. 80% patients have cytopenias on presentation. Splenomegaly is a predominant feature. Infectious complications are common, due to both the underlying immunosuppression from cytopenias and myelosuppressive therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational objective</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The given history of multiple bone pain, high ESR and calcium levels, with &gt;20% plasma cells and lytic lesions is characteristic of plasma cell leukemia.</span></li></ul>",
    "correct_choice_id": 1958,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 493,
    "choices": [
      {
        "id": 1968,
        "text": "<p><span style=\"font-size:12.0pt;\">Fibrosarcoma</span></p>"
      },
      {
        "id": 1969,
        "text": "<p><span style=\"font-size:12.0pt;\">Osteosarcoma</span></p>"
      },
      {
        "id": 1970,
        "text": "<p><span style=\"font-size:12.0pt;\">Undifferentiated sarcoma</span></p>"
      },
      {
        "id": 1971,
        "text": "<p><span style=\"font-size:12.0pt;\">Malignant peripheral nerve sheath tumor</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which metabolic condition has phosphaturia and osteomalacia?</span></p>",
    "unique_key": "Q7744013",
    "question_audio": null,
    "question_video": null,
    "map_id": 518,
    "difficulty_level": "intermediate",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Fibrosarcoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Hypophosphatemic Vitamin D resistant rickets or osteomalacia can be associated with:</span><ul><li><span style=\"font-size:12.0pt;\">Hemangiopericytomas</span></li><li><span style=\"font-size:12.0pt;\">Fibrosarcoma</span></li><li><span style=\"font-size:12.0pt;\">GCT</span></li><li><span style=\"font-size:12.0pt;\">Osteosarcoma</span></li><li><span style=\"font-size:12.0pt;\">Pigmented Villo Nodular synovitis</span></li></ul></li><li><span style=\"font-size:12.0pt;\">The mediator is phosphatonin \u2013 <strong>FGF-23</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>It is a reversible condition along with malignancy.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>FIBROSARCOMA</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Fibrosarcomas are malignant neoplasms composed of fibroblasts with collagen production and a \"herringbone\" architecture.</span></li><li><span style=\"font-size:12.0pt;\">Depending upon the origin, there are&nbsp;<strong>2 main categories of fibrosarcomas</strong>: bone and soft tissue tumors.</span></li><li><span style=\"font-size:12.0pt;\">Fibrosarcomas can be subdivided into&nbsp;<strong>2 types</strong>: infantile or congenital fibrosarcomas&nbsp;and adult-type fibrosarcomas.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Infantile fibrosarcomas rarely metastasize, while adult-type fibrosarcomas are highly malignant</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Fibrosarcomas typically originate from fascia and tendons of soft tissue but can also occur in bones as a primary or secondary tumor within the medullary canal or the periosteum.</span></li><li><span style=\"font-size:12.0pt;\">Prior bone damage, from trauma or radiotherapy, may give rise to fibrosarcomas of the bone.</span></li><li><span style=\"font-size:12.0pt;\">Adult fibrosarcoma is most common in middle-aged and older adults.</span></li><li><span style=\"font-size:12.0pt;\">Males have a slight predominance, most commonly involving the deep soft tissues of the extremities, trunk, head, and neck.</span></li><li><span style=\"font-size:12.0pt;\">The bony fibrosarcoma of the femur and tibia are the most common sites for lesions, followed by the humerus.</span></li><li><span style=\"font-size:12.0pt;\">These pathological lesions are typically metaphyseal in origin.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Oncogenic Osteomalacia</strong> is a paraneoplastic syndrome of renal phosphate wasting caused by fibrosarcoma. Patients may present with osteopenia and pathologic fractures.</span></li><li><span style=\"font-size:12.0pt;\">The tumor secretes a&nbsp;humoral factor (\"phosphatonin\")&nbsp;that affects the proximal renal tubules \u2192 reduces calcitriol production in the kidney \u2192 inhibits phosphate transport \u2192 leads to increased renal phosphate excretion, hypophosphatemia and osteomalacia</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tumor-induced osteomalacia and phosphaturia are not seen in <strong>Osteosarcoma (Option B), Undifferentiated sarcoma (Option C), </strong>and<strong> Malignant peripheral nerve sheath tumor (Option D).</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Tumour-induced osteomalacia&nbsp;(TIO), is a rare paraneoplasatic syndrome found in &gt;95% of benign tumours that secrete fibroblast growth factor 23 \u2013 a phosphaturic circulating hormone.</span></li></ul>",
    "correct_choice_id": 1968,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 431,
    "choices": [
      {
        "id": 1720,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Osteosarcoma &ndash; Sunray appearance</span></span></span></p>"
      },
      {
        "id": 1721,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chondroblastoma &ndash; Soap bubble appearance</span></span></span></p>"
      },
      {
        "id": 1722,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ewing&#39;s sarcoma &ndash; Onion peel appearance</span></span></span></p>"
      },
      {
        "id": 1723,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Secondaries of spine &ndash; Winking owl sign</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is wrongly matched? </span></span></p>",
    "unique_key": "Q1846215",
    "question_audio": null,
    "question_video": null,
    "map_id": 456,
    "difficulty_level": "beginner",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Chondroblastoma &ndash; Soap bubble appearance</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">CLASSICAL RADIOLOGICAL FEATURES</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/screenshot-2024-02-12-123751_nJHcGOb.jpg\" style=\"height:367px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Note:&nbsp;</span></strong><span style=\"font-size:12.0pt\">While marking answers on </span><strong><span style=\"font-size:12.0pt\">calcifications</span></strong> <strong><span style=\"font-size:12.0pt\">choose cartilaginous tumors before osteogenic&nbsp;</span></strong><span style=\"font-size:12.0pt\">and </span><strong><span style=\"font-size:12.0pt\">amongst cartilaginous prefer malignant more than benign.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Osteosarcoma &ndash; Sunray appearance. </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture2.jpg\" style=\"height:258px; width:300px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Ewing&rsquo;s sarcoma &ndash; Onion peel appearance. </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture3.jpg\" style=\"height:319px; width:250px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Secondaries of spine &ndash; Winking owl sign.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture4.jpg\" style=\"height:382px; width:250px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chondroblastoma shows chicken wire calcification on biopsy. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture5.jpg\" style=\"height:301px; width:300px\" /></span></span></span></p>",
    "correct_choice_id": 1721,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 455,
    "choices": [
      {
        "id": 1816,
        "text": "<p><span style=\"font-size:12.0pt;\">Blade of grass deformity</span></p>"
      },
      {
        "id": 1817,
        "text": "<p><span style=\"font-size:12.0pt;\">Shepherd crook deformity</span></p>"
      },
      {
        "id": 1818,
        "text": "<p><span style=\"font-size:12.0pt;\">Chicken wire appearance</span></p>"
      },
      {
        "id": 1819,
        "text": "<p><span style=\"font-size:12.0pt;\">Corduroy appearance</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">X-ray proximal femur in a patient with pain in hip is given below. The deformity shown is:</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture22.jpg\" alt=\"\" width=\"250\" height=\"356\"></p>",
    "unique_key": "Q9304142",
    "question_audio": null,
    "question_video": null,
    "map_id": 480,
    "difficulty_level": "beginner",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Shepherd crook deformity</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>RADIOGRAPHIC FINDINGS IN FIBROUS DYSPLASIA</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">In long bones, the fibrous dysplastic lesions have <strong>ground-glass appearance.</strong></span></li><li><span style=\"font-size:12.0pt;\">Fibrous dysplasia of proximal femur has <strong>shepherd crook deformity</strong>.</span></li><li><span style=\"font-size:12.0pt;\">The multiloculated translucent lesion may be surrounded by a sclerotic rim the so called <strong>\u2018Rind sign\u2019.</strong></span></li></ul><p>&nbsp;</p><p style=\"text-align:center;\"><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture23.jpg\" alt=\"\" width=\"500\" height=\"281\"></strong></span><br><span style=\"font-size:12.0pt;\"><strong>(A) Shepherd crook deformity (B) Rind sign</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Involvement of facial bones may create a leonine appearance<strong> (leontiasis ossea)</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Blade of grass deformity.&nbsp;</strong>The&nbsp;<strong>blade of grass sign&nbsp;</strong>refers to the lucent leading edge in a long bone seen during the lytic phase of&nbsp;Paget disease of bone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture24.jpg\" alt=\"\" width=\"300\" height=\"373\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Chicken wire appearance.&nbsp;</strong>Chicken wire calcification is classically seen in the <strong>chondroblastoma.</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture25.jpg\" alt=\"\" width=\"300\" height=\"211\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Corduroy appearance.&nbsp;</strong>This is seen in the radiographic image of the spine in <strong>hemangioma</strong> of the bone, as thickened, vertically oriented trabeculae, giving a <strong>jailhouse appearance.</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture26.jpg\" alt=\"\" width=\"250\" height=\"299\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The given image in the question shows the s<strong>hepherd crook deformity of the proximal femur</strong>, seen in case of <strong>fibrous dysplasia</strong> of the bone.</span></li></ul>",
    "correct_choice_id": 1817,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 457,
    "choices": [
      {
        "id": 1824,
        "text": "<p><span style=\"font-size:12.0pt;\">Cystic lesion</span></p>"
      },
      {
        "id": 1825,
        "text": "<p><span style=\"font-size:12.0pt;\">Rapidly growing</span></p>"
      },
      {
        "id": 1826,
        "text": "<p><span style=\"font-size:12.0pt;\">Malignant disease</span></p>"
      },
      {
        "id": 1827,
        "text": "<p><span style=\"font-size:12.0pt;\">MC site is tibia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">True about Ameloblastoma is:</span></p>",
    "unique_key": "Q8378071",
    "question_audio": null,
    "question_video": null,
    "map_id": 482,
    "difficulty_level": "difficult",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Cystic lesion</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>AMELOBLASTOMA</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Most common site of ameloblastoma is mandible</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Most common site of ameloblastoma of long bones (i.e. adamantinoma) is <strong>Tibial diaphysis</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Adamantinoma is a <strong>slow growing</strong> <strong>benign locally aggressive</strong> tumor with late metastasis.</span></li><li><span style=\"font-size:12.0pt;\">Well demarcated lytic (cystic) or mixed lytic/sclerotic lesion involving the cortex.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Rapidly growing</strong>. This is false. Ameloblastoma are slow growing tumors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Malignant disease</strong>. This is false. Ameloblastoma are benign tumors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. MC site is tibia</strong>. This is false. The most common site is the posterior mandible in the area of the molar teeth. Among the long bones, tibial diaphysis is a common site. In the long bones, this tumor is known as adamantinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Ameloblastoma is a cystic benign tumor that causes cystic degeneration of the bone.</span></li></ul>",
    "correct_choice_id": 1824,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 454,
    "choices": [
      {
        "id": 1812,
        "text": "<p><span style=\"font-size:12.0pt;\">2, 3, 4</span></p>"
      },
      {
        "id": 1813,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3</span></p>"
      },
      {
        "id": 1814,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 4</span></p>"
      },
      {
        "id": 1815,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 5</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">McCune-Albright syndrome features are:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">High calcium</span></li><li><span style=\"font-size:12.0pt;\">Presents around puberty</span></li><li><span style=\"font-size:12.0pt;\">Cysts in long bones</span></li><li><span style=\"font-size:12.0pt;\">Precocious puberty</span></li><li><span style=\"font-size:12.0pt;\">High ACTH levels</span></li></ol>",
    "unique_key": "Q6883738",
    "question_audio": null,
    "question_video": null,
    "map_id": 479,
    "difficulty_level": "intermediate",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 2, 3, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>McCune-Albright syndrome refers to polyostotic fibrous dysplasia, cutaneous pigmentation (caf\u00e9 au lait spots), and endocrine abnormalities (Precocious puberty).</strong></span></li><li><span style=\"font-size:12.0pt;\">The cafe au lait spots seen in Albright-McCune syndrome have characteristically irregular ragged borders (commonly called <strong>\u201ccoast of Maine\u201d</strong> borders), as opposed to the smoothly marginated borders <strong>(\u201ccoast of California\u201d)</strong> of the spots seen in neurofibromatosis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>It occurs due to gain of function mutations of GNAS (Gs protein) leading to increased cAMP.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture21.jpg\" alt=\"\" width=\"300\" height=\"251\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>X-ray upper end humerus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">McCune-Albright Syndrome is characterized by a triad of <strong>polyostotic fibrous dysplasia</strong> of the bones (the replacement of the normal bones and marrow by the fibrous tissue and small woven spicules of bone); <strong>precocious puberty</strong> (peripheral and due to activation of ovarian or testicular tissue); and <strong>caf\u00e9-au-late spots</strong> (cutaneous pigmentation).</span></li><li><span style=\"font-size:12.0pt;\">It presents during the time of <strong>puberty</strong>.</span></li><li><span style=\"font-size:12.0pt;\">The bones presents with <strong>cystic lesions</strong> with radiographs presenting thinned cortex and intramedullary <strong>ground glass appearance</strong>.</span></li><li><span style=\"font-size:12.0pt;\">There is <strong>increased</strong> level of <strong>growth hormones</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Hyperthyroidism</strong> is a feature.</span></li></ul>",
    "correct_choice_id": 1812,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 436,
    "choices": [
      {
        "id": 1740,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">1, 4</span></span></span></p>"
      },
      {
        "id": 1741,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">2, 1</span></span></span></p>"
      },
      {
        "id": 1742,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">2, 3</span></span></span></p>"
      },
      {
        "id": 1743,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">2, 4</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Radio-resistant bone tumor among the following are:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Ewing&rsquo;s Sarcoma</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Osteosarcoma</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Multiple myeloma</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Chondrosarcoma</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Lymphoma</span></span></span></li>\r\n</ol>",
    "unique_key": "Q3370067",
    "question_audio": null,
    "question_video": null,
    "map_id": 461,
    "difficulty_level": "intermediate",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Ans. D) 2, 4</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">RADIO-RESISTANT BONE TUMOR</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Metastatic renal cell carcinoma </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Liposarcoma</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Synovial cell sarcoma </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Osteosarcoma (most resistant)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Malignant fibrous histiocytoma </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fibrosarcoma of bone</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rhabdomyosarcoma </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chondrosarcoma</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fibrosarcoma</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Malignant GCT</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Osteosarcoma&nbsp;</span></strong><span style=\"font-size:12.0pt\">(<strong>most</strong> <strong>radioresistant</strong>) and <strong>Chondrosarcoma</strong> as the radio-resistant tumors. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ewing&rsquo;s sarcoma&nbsp;</span></strong><span style=\"font-size:12.0pt\">(<strong>most</strong> <strong>radio-sensitive</strong>), <strong>Multiple myeloma</strong>, and <strong>Lymphoma</strong> are radio-sensitive tumors. </span></span></span></li>\r\n</ul>",
    "correct_choice_id": 1743,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 478,
    "choices": [
      {
        "id": 1908,
        "text": "<p><span style=\"font-size:12.0pt;\">2, 3, 4</span></p>"
      },
      {
        "id": 1909,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3</span></p>"
      },
      {
        "id": 1910,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 4</span></p>"
      },
      {
        "id": 1911,
        "text": "<p><span style=\"font-size:12.0pt;\">2, 4, 5</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is/are true about Ewing sarcoma?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Vascular origin</span></li><li><span style=\"font-size:12.0pt;\">Ewing\u2019s sarcoma is second most common primary malignant bone tumor in children and adolescent after Osteosarcoma</span></li><li><span style=\"font-size:12.0pt;\">Metaphysis of long bone is most common site</span></li><li><span style=\"font-size:12.0pt;\">Fever and weight loss may be present</span></li><li><span style=\"font-size:12.0pt;\">Surgery is very useful in management</span></li></ol>",
    "unique_key": "Q8981559",
    "question_audio": null,
    "question_video": null,
    "map_id": 503,
    "difficulty_level": "intermediate",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 2, 4, 5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>EWING SARCOMA</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Vascular origin:</strong> Incorrect \u2014 Ewing sarcoma is a neuroectodermal tumor, not of vascular origin. It arises from primitive neuroectodermal cells (PNET).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Ewing\u2019s sarcoma is the second most common primary malignant bone tumor in children and adolescents after osteosarcoma:</strong> Correct \u2014 Osteosarcoma is the first, and Ewing sarcoma is second most common tumor in this age group.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Metaphysis of long bone is the most common site:</strong> Incorrect \u2014 Ewing sarcoma most commonly affects the diaphysis of long bones (like femur, tibia, humerus) and also flat bones like pelvis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Fever and weight loss may be present:</strong> Correct \u2014 Ewing sarcoma can mimic infection with systemic signs like fever, weight loss, and leukocytosis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Surgery is very useful in management:</strong> Correct \u2014 Surgery plays a key role along with chemotherapy and radiotherapy for local control and improving outcomes.&nbsp;</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Ewing\u2019s sarcoma is the 2<sup>nd</sup> most common primary malignant tumor in children &lt;10 years of age and adolescents after osteosarcoma.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Diaphysis of the long bones is the most common site of origin.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Patients may also present with systemic symptoms like fever and weight loss.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Surgery is a useful treatment option.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Best results are achieved by pre-operative chemotherapy, followed by wide excision or amputation, followed by chemotherapy for 1 year.&nbsp;</span></li></ul>",
    "correct_choice_id": 1911,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 449,
    "choices": [
      {
        "id": 1792,
        "text": "<p><span style=\"font-size:12.0pt;\">Giant cells</span></p>"
      },
      {
        "id": 1793,
        "text": "<p><span style=\"font-size:12.0pt;\">Mononuclear cells</span></p>"
      },
      {
        "id": 1794,
        "text": "<p><span style=\"font-size:12.0pt;\">Both</span></p>"
      },
      {
        "id": 1795,
        "text": "<p><span style=\"font-size:12.0pt;\">None</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">GCT malignant component is:</span></p>",
    "unique_key": "Q3595804",
    "question_audio": null,
    "question_video": null,
    "map_id": 474,
    "difficulty_level": "intermediate",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Mononuclear cells</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Microscopically, giant cell tumors are composed of many multinucleated giant cells (typically 40-60 nuclei per cell) in a sea of mononuclear stromal cells (malignant cells).</span></li><li><span style=\"font-size:12.0pt;\">The nuclei of the mononuclear cells are identical to the nuclei of the giant cells, a feature that helps to distinguish giant cell tumors from other tumors that may contain many giant cells.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Giant cells</strong>. The multinucleated giant cells in the GCT are benign in nature.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational objective</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The mononuclear stromal cells around the multinucleated giant cells in the GCT are the malignant components of the tumor.</span></li></ul>",
    "correct_choice_id": 1793,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 442,
    "choices": [
      {
        "id": 1764,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Giant cell tumor</span></span></span></p>"
      },
      {
        "id": 1765,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Simple Bone Cyst</span></span></span></p>"
      },
      {
        "id": 1766,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Adamantinoma </span></span></span></p>"
      },
      {
        "id": 1767,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ewing&#39;s sarcoma</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old male presented with hip pain for last 6 months. Hip X-ray is as shown below. What is the likely diagnosis? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,&quot;sans-serif&quot;\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/picture17.jpg\" style=\"height:203px; width:300px\" /></span></span></p>",
    "unique_key": "Q6782327",
    "question_audio": null,
    "question_video": null,
    "map_id": 467,
    "difficulty_level": "intermediate",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Giant cell tumor</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">GIANT CELL TUMOR</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">They typically occur in patients <strong>20-40 years old</strong>, and there is a slight <strong>female predominance</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The most common location for this tumor is the <strong>distal femur</strong>, followed by the <strong>proximal tibia</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">GCT has an <strong>egg shell crackling</strong> on palpation.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Although these tumors typically are benign, pulmonary metastases occur in approximately 3% of patients.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Radiographic findings&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">often are <strong>diagnostic</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The lesions are <strong>eccentrically</strong> located in the <strong>epiphyses</strong> of long bones and usually about the subchondral bone. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture13.jpg\" style=\"height:196px; width:300px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Microscopically, giant cell tumors are composed of many multinucleated giant cells (typically 40-60 nuclei per cell) in a sea of mononuclear stromal cells (malignant cells). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">The nuclei of the mononuclear cells are identical to the nuclei of the giant cells</span></strong><span style=\"font-size:12.0pt\">, a feature that helps to distinguish giant cell tumors from other tumors that may contain many giant cells.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Giant cell variants (Tumor with giant cells):</span></strong></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Brown tumor of hyperparathyroidism</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Aneurysmal bone cyst <strong>(closest)</strong> and unicameral bone cyst</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Non-ossifying fibroma <strong>(commonest) </strong>and Fibrous dysplasia</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Osteoblastoma and Osteosarcoma</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Metastatic carcinoma with giant cells</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chondromyxoid fibroma and Chondroblastoma</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pigmented villonodular synovitis (mostly occurring in knee)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Benign fibrous histiocytoma</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Malignant fibrous histiocytoma</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fibrosarcoma</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Clear cell chondrosarcoma.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Treatment options:</span></strong></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Extended Curettage&nbsp;</span></strong><span style=\"font-size:12.0pt\">by PMMA or phenol or liquid nitrogen and <strong>bone grafting</strong> &ndash; procedure of choice for most lesions</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Excision of lower end of ulna, upper end of fibula</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Excision and replacement by vascularized bone graft &ndash; lower end of radius where upper end of fibula is grafted</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Excision and arthrodesis or prosthetic replacement or Turn-O-Plasty (Bone ends are cut and rotated) &ndash; lower end femur and upper end tibia</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Amputation</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Malignant recurrent GCT &ndash; Radiotherapy</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Simple bone cyst.&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Unicameral bone cysts are most common in the proximal humerus and femur. The lesions are most active during skeletal growth and <strong>usually heal spontaneously at maturity. </strong>Unicameral bone cysts <strong>are often asymptomatic</strong>, unless a pathological fracture has occurred. Plain radiographs reveal a <strong>centrally located, purely lytic lesion with a well-marginated outline. </strong>Occasionally (20%), a thinned cortical fragment fractures and falls into the base of the lesion confirming its empty cystic nature. <strong>This &ldquo;fallen fragment&rdquo; sign is pathognomonic of a unicameral bone cyst, bone fragment, may also hinge around and move with fluid called as trap door sign. </strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture14.jpg\" style=\"height:298px; width:300px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fallen fragment (leaf) sign</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Adamantinoma.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Adamantinomas are rare, <strong>low-grade malignant</strong> bone tumors&nbsp;that predominately&nbsp;affect&nbsp;the <strong>diaphyses</strong> and <strong>metaphyses</strong> of the <strong>tibia</strong>. The tumor is called <strong>adamantinoma</strong> due to its histological similarity to ameloblastoma, often found in the mandible.&nbsp;Histopathologically, adamantinoma&nbsp;displays biphasic patterns consisting of epithelial cells and osteofibrous components. </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">On x-ray, it appears as a well-circumscribed, cortical tumor with a multilobulated, osteolytic pattern. Intralesional opacities, septation, and peripheral sclerosis may also be seen. These multifocal radiolucencies, surrounded by ring-shaped densities, produce the characteristic <strong>&#39;&#39;soap-bubble&#39;&#39; appearance</strong>. The lesion is typically confined&nbsp;within the intracortical region and extends longitudinally along the bone. However, in some cases, it can result in cortical destruction and invade the medullary cavity or adjacent periosteum and soft tissues.&nbsp;In such cases, a lamellar or solid periosteal reaction is typically associated with the&nbsp;lesion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture15.jpg\" style=\"height:322px; width:300px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Ewing&rsquo;s sarcoma.&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ewing sarcoma is the second most common (after osteosarcoma) in patients younger than 30 years of age. Classically, Ewing sarcoma appears radiographically as a <em>destructive lesion in the <strong>diaphysis&nbsp;</strong></em>of a long bone with an &ldquo;<strong>onion skin&rdquo; periosteal reaction</strong>. In reality, Ewing sarcoma more often originates in the metaphysis of a long bone, but frequently extends for a considerable distance into the diaphysis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture16.jpg\" style=\"height:199px; width:300px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The given x-ray in the question shows eccentric giant cell tumor of the proximal femur. &nbsp;</span></span></span></li>\r\n</ul>",
    "correct_choice_id": 1764,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 426,
    "choices": [
      {
        "id": 1700,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">2, 3, 4</span></span></span></p>"
      },
      {
        "id": 1701,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">1, 2, 3</span></span></span></p>"
      },
      {
        "id": 1702,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">1, 2, 4</span></span></span></p>"
      },
      {
        "id": 1703,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">1, 2, 5</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which among the following is/are metaphyseal tumor?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Chondrosarcoma</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Enchondroma</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Giant cell tumor </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Ameloblastoma</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Osteosarcoma</span></span></span></li>\r\n</ol>",
    "unique_key": "Q2611438",
    "question_audio": null,
    "question_video": null,
    "map_id": 451,
    "difficulty_level": "beginner",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Ans. D) 1, 2, 5</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/screenshot-2024-02-12-122107.jpg\" style=\"height:374px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Note:</span></strong><span style=\"font-size:12.0pt\"> Osteomyelitis also starts in metaphysis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture1.jpg\" style=\"height:523px; width:600px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Sites of bone tumors</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Among the given options, <strong>Chondrosarcoma, Enchondroma and Osteosarcoma</strong> are the tumors that affect the <strong>metaphyseal</strong> region of the bone whereas <strong>Giant cell tumor</strong> affects the <strong>epiphyseal</strong> region of the bone. &nbsp;</span></span></span></li>\r\n</ul>",
    "correct_choice_id": 1703,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 428,
    "choices": [
      {
        "id": 1708,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fibrous dysplasia </span></span></span></p>"
      },
      {
        "id": 1709,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Brodie&rsquo;s abscess</span></span></span></p>"
      },
      {
        "id": 1710,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Giant cell tumor</span></span></span></p>"
      },
      {
        "id": 1711,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Ewing&rsquo;s sarcoma</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not a type of geographic lesion of bone? </span></span></p>",
    "unique_key": "Q1743715",
    "question_audio": null,
    "question_video": null,
    "map_id": 453,
    "difficulty_level": "difficult",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Ans. D) Ewing&rsquo;s sarcoma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Geographic bone lesion</span></strong><span style=\"font-size:12.0pt\"> implies a lesion with a sharply-defined border. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This can also be described as a <strong>narrow zone of transition</strong> between pathologic and normal bone. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A geographic appearance implies a <strong>benign</strong> or less aggressive tumour.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/screenshot-2024-02-12-122920.jpg\" style=\"height:537px; width:1000px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Fibrous dysplasia</span></strong><span style=\"font-size:12.0pt\">. It is a <strong>type 1A </strong>geographic lesion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Brodie&rsquo;s abscess</span></strong><span style=\"font-size:12.0pt\">. It is also a geographic lytic lesion. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Giant cell tumor</span></strong><span style=\"font-size:12.0pt\">. It is a <strong>type 1B </strong>geographic lesion.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective</span></strong><span style=\"font-size:12.0pt\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ewing&rsquo;s sarcoma is a type of a <strong>permeative </strong>lytic lesion which is poorly demarcated and numerous. </span></span></span></li>\r\n</ul>",
    "correct_choice_id": 1711,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ]
  },
  {
    "id": 433,
    "choices": [
      {
        "id": 1728,
        "text": "<p><span style=\"font-size:12.0pt;\">Neuroblastoma</span></p>"
      },
      {
        "id": 1729,
        "text": "<p><span style=\"font-size:12.0pt;\">Ganglioneuroma</span></p>"
      },
      {
        "id": 1730,
        "text": "<p><span style=\"font-size:12.0pt;\">Wilms' tumor</span></p>"
      },
      {
        "id": 1731,
        "text": "<p><span style=\"font-size:12.0pt;\">Ewing's sarcoma</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following childhood tumors most frequently metastasizes to the bone?</span></p>",
    "unique_key": "Q6044584",
    "question_audio": null,
    "question_video": null,
    "map_id": 458,
    "difficulty_level": "intermediate",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Neuroblastoma</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Neuroblastoma is a cancer that arises from immature nerve cells (neuroblasts) typically found in the adrenal glands, abdomen, chest, neck, or pelvis.&nbsp;</span></li><li><span style=\"font-size:16px;\">It is one of the most common solid extracranial tumors in children.</span></li><li><span style=\"font-size:16px;\">Neuroblastoma is known for its aggressive nature and high propensity to metastasize early in its course.</span></li><li><span style=\"font-size:16px;\">The <strong>bone and bone marrow</strong> are exceptionally common sites for neuroblastoma metastasis.&nbsp;</span></li><li><span style=\"font-size:16px;\">In many cases, bone or bone marrow involvement is present at the time of initial diagnosis, indicating advanced-stage disease.&nbsp;</span></li><li><span style=\"font-size:16px;\">This predilection for bone metastasis is a key characteristic of neuroblastoma that differentiates it from other childhood cancers in terms of metastatic patterns.&nbsp;</span></li><li><span style=\"font-size:16px;\">These metastases can cause bone pain, pathological fractures, and cytopenias due to bone marrow involvement.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Ganglioneuroma</strong>.&nbsp;</span><span style=\"color:black;font-size:16px;\">Ganglioneuroma is an uncommon <strong>neurogenic tumor</strong> arising from sympathetic ganglia. Most of the patients are <strong>older than 10&nbsp;years</strong>. The posterior mediastinum is the main localization followed by the retroperitoneum and cervical region.&nbsp;</span><span style=\"font-size:16px;\">This is a <strong>benign&nbsp;</strong>tumor. Benign tumors do not metastasize.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Wilm\u2019s tumor</strong>. </span><span style=\"color:black;font-size:16px;\">Wilms tumor, or&nbsp;nephroblastoma, is the most common <strong>renal cancer</strong> in the pediatric age group. Wilms tumor&nbsp;is typically&nbsp;found in children <strong>younger than five years</strong> of age. The most common site of metastatic spread of Wilms tumor is the <strong>lungs</strong>&nbsp;</span><span style=\"font-size:16px;\">(most frequent) and the liver. Bone metastases from Wilms' tumor are relatively rare.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:16px;\"><strong>Option D. Ewing\u2019s sarcoma</strong>.&nbsp;</span><span style=\"font-size:16px;\">This is a <strong>primary bone tumor</strong> (or sometimes soft tissue tumor that invades bone). This means it originates <i>in</i> the bone itself. Therefore, it doesn't \"metastasize <i>to</i> the bone\" from a distant primary site in the same way.&nbsp;</span><span style=\"color:black;font-size:16px;\">Ewing\u2019s sarcoma mostly happens in <strong>children and young adults</strong>, although it can happen at any age. It most often begins in the leg bones and pelvis, but it can happen in any bone. It can involve the muscle and the soft tissues around the tumor as well. The cells can also metastasize to other areas of the body, including the <strong>bone marrow, lungs, kidneys, heart, adrenal glands&nbsp;</strong>and other soft tissues.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"color:black;font-size:16px;\">Neuroblastoma is the most common tumor in children that <strong>metastasize to the bone</strong> frequently.&nbsp;</span></li><li><span style=\"color:black;font-size:16px;\">It is the most frequently-occurring <strong>extracranial</strong> childhood tumor, classified as an embryonal neuroendocrine tumor, originating from neural crest progenitor cells.&nbsp;</span></li><li><span style=\"color:black;font-size:16px;\">Hence, it can occur anywhere along the <strong>sympathetic nervous system</strong>, including the superior cervical, paraspinal, and celiac ganglia; the majority arise in the adrenal glands.</span><span style=\"font-size:16px;\"><strong>&nbsp;</strong></span></li><li><span style=\"color:black;font-size:16px;\">Neuroblastoma may <strong>metastasize to lymph nodes, bone marrow, liver, skin and bones</strong>.&nbsp;</span></li><li><span style=\"font-size:16px;\"><strong>B</strong>one to bone metastasis is seen in <strong>O</strong>steosarcoma, <strong>N</strong>euroblastoma, <strong>E</strong>wing's Sarcoma [</span><span style=\"color:red;font-size:16px;\"><strong>B O N E</strong></span><span style=\"font-size:16px;\">] (Maximum incidence of a particular tumor type).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture6.jpg\" alt=\"\" width=\"500\" height=\"363\"></span></p>",
    "correct_choice_id": 1728,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 437,
    "choices": [
      {
        "id": 1744,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The femur and tibia are the commonest bones involved</span></span></span></p>"
      },
      {
        "id": 1745,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Radiologically appears as a radiolucent lesion surrounded by dense bone</span></span></span></p>"
      },
      {
        "id": 1746,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is a benign bone tumor, presents with severe pain that is typically relieved by aspirin</span></span></span></p>"
      },
      {
        "id": 1747,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">All of the above</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is true regarding osteoid osteoma? </span></span></p>",
    "unique_key": "Q5380971",
    "question_audio": null,
    "question_video": null,
    "map_id": 462,
    "difficulty_level": "beginner",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) All of the above</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">OSTEOID OSTEOMA</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MC in Femur Diaphysis</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is <strong>commonest benign true bone tumor</strong>, exceeded in incidence only by osteochondroma and non-ossifying fibroma.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>typical patient with an osteoid osteoma has pain that is worse at night and is relieved by aspirin</strong> or other nonsteroidal anti-inflammatory medications. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">When the lesion is in a vertebra, scoliosis may occur.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Both Osteoblastic &amp; Osteoclastic cells are seen.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The lesion has central lysis with surrounding sclerosis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Growing center is called as <strong>Nidus (Seed).</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">CT is the best</span></strong><span style=\"font-size:12.0pt\"> study to identify the nidus and confirm the diagnosis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">D/D of osteoid osteoma is bone island.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Radiofrequency ablation</span></strong><span style=\"font-size:12.0pt\"> is used for osteoid osteoma.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture7.jpg\" style=\"height:318px; width:300px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Surgical management involves removal of the entire nidus done by burr-down technique.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Note:</span></strong><span style=\"font-size:12.0pt\"> The literature now supports that osteoid osteoma is showing higher incidence in metaphysis. Even then the clinical scenario given is such that it is mentioned as diaphyseal.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Osteoid osteoma is a <strong>benign</strong> bone tumor that presents with <strong>severe pain</strong>, which is relieved by aspirin or other NSAID medications. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>femur</strong> and <strong>tibia</strong> are the most commonly involved bones. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Radiologically, it appears as a <strong>radiolucent</strong> lesion surrounded by dense bone. </span></span></span></li>\r\n</ul>",
    "correct_choice_id": 1747,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette"
    ]
  },
  {
    "id": 439,
    "choices": [
      {
        "id": 1752,
        "text": "<p><span style=\"font-size:12.0pt;\">Maffucci syndrome</span></p>"
      },
      {
        "id": 1753,
        "text": "<p><span style=\"font-size:12.0pt;\">Felty syndrome</span></p>"
      },
      {
        "id": 1754,
        "text": "<p><span style=\"font-size:12.0pt;\">Ollier's disease</span></p>"
      },
      {
        "id": 1755,
        "text": "<p><span style=\"font-size:12.0pt;\">Both A and C</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Development of Chondrosarcomas is related with:</span></p>",
    "unique_key": "Q5572994",
    "question_audio": null,
    "question_video": null,
    "map_id": 464,
    "difficulty_level": "intermediate",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Both A and C</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"color:#222222;font-size:12.0pt;\">Chondromas or <strong>Chondroasarcomas</strong> are <strong>benign</strong> lesions of <strong>hyaline cartilage</strong>.&nbsp;</span></li><li><span style=\"color:#222222;font-size:12.0pt;\">They are the&nbsp;most common tumor of the <strong>small bones</strong> of the hands and feet.&nbsp;</span></li><li><span style=\"color:#222222;font-size:12.0pt;\">They&nbsp;usually <strong>arise in the medullary canal</strong>, where they are referred to as&nbsp;\u201c<strong>enchondromas</strong>\u201d.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\"><strong>Secondary chondrosarcomas</strong> arise at the site of a <strong>preexisting benign cartilage lesion</strong>.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">They occur most frequently in the setting of multiple enchondromas and <strong>multiple hereditary exostoses</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Maffucci\u2019s syndrome</strong> is a&nbsp;<strong>rare non-hereditary&nbsp;</strong>disorder characterized by <strong>multiple enchondromas</strong> (benign cartilage tumors), <strong>subcutaneous hemangiomas</strong> (tumors of blood vessels) and <strong>phleboliths</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Individuals with Maffucci syndrome have a significantly increased <strong>risk of developing chondrosarcomas</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture8.jpg\" alt=\"\" width=\"400\" height=\"245\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Enchondroma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture9.jpg\" alt=\"\" width=\"400\" height=\"191\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Mafucci syndrome: (A) Hemangiomas (B) Phleboliths and Enchondromas</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"color:black;font-size:12.0pt;\">When <strong>multiple enchondromas</strong> are present, the condition is called as <strong>Ollier disease</strong>.&nbsp;</span></li><li><span style=\"color:black;font-size:12.0pt;\">Ollier disease is characterized by an asymmetric distribution of cartilage lesions.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Malignant transformation to chondrosarcoma may occur in <strong>&lt;2% in solitary</strong> cases, <strong>30% in Ollier\u2019s&nbsp;</strong>disease and <strong>100% in Maffucci\u2019s</strong> syndrome.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Felty syndrome</strong>.</span><span style=\"color:black;font-size:12.0pt;\"> Felty syndrome is an uncommon extra-articular manifestation of seropositive rheumatoid arthritis (RA) characterized by RA, <strong>neutropenia</strong> (ANC&lt;1500 mm<sup>3</sup>), and <strong>splenomegaly</strong>. <strong>HLA-DR4</strong> has been noted to be present in &gt;90% of Felty syndrome cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Both Maffucci syndrome and Ollier's disease are well-established conditions that predispose individuals to the development of chondrosarcomas due to the presence of multiple enchondromas.</span></p>",
    "correct_choice_id": 1755,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 440,
    "choices": [
      {
        "id": 1756,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chondromyxoid fibroma </span></span></span></p>"
      },
      {
        "id": 1757,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Osteosarcoma</span></span></span></p>"
      },
      {
        "id": 1758,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bone cyst with fracture </span></span></span></p>"
      },
      {
        "id": 1759,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fibrosis cystica</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">X-ray of Tibia of an adolescent boy is shown. Probable diagnosis is: </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,&quot;sans-serif&quot;\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/picture16.jpg\" style=\"height:207px; width:300px\" /></span></span></p>",
    "unique_key": "Q7036221",
    "question_audio": null,
    "question_video": null,
    "map_id": 465,
    "difficulty_level": "difficult",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Chondromyxoid fibroma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CHONDROMYXOID FIBROMA</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chondromyxoid fibroma is a <strong>rare</strong> lesion of <strong>cartilaginous</strong> origin. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Although chondromyxoid fibromas may occur at any age, most commonly it occur in patients <strong>10-30 years</strong> old. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Any bone may be involved, but the <strong>proximal tibia</strong> is the most common location. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In contrast to other cartilaginous lesions, radiographic evidence of intralesional calcification usually is absent. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Plain radiograph shows<strong> </strong></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">lobulated or oval eccentric lytic lesion with well-defined sclerotic margin, often expansile, with long axis parallel to long axis of long bone. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">There is <strong>no periosteal reaction</strong>, unless a complicating fracture is present. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The </span><span style=\"font-size:12.0pt\">geographic bone destruction</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is almost 100%. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">There is a presence of <strong>septations</strong> (pseudotrabeculation) in about 60%&nbsp;cases. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Treatment</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> consists of resection or extended curettage</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture10_Mtz683n.jpg\" style=\"height:245px; width:500px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Osteosarcoma. </span></strong><span style=\"font-size:12.0pt\">Radiographically, the p</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">eriosteal reaction may be seen in the form of &ldquo;<strong>Codman&rsquo;s triangle</strong>&rdquo;, or it may have a &ldquo;<strong>sunburst</strong>&rdquo; or &ldquo;<strong>hair on end</strong>&rdquo; appearance<strong>. </strong>The codman&rsquo;s triangle is formed by the periosteal lifting. There is also new bone formation in the soft tissues along with permeative pattern of bone destruction.<strong> </strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture11_SU3Ajlv.jpg\" style=\"height:211px; width:300px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Codman&rsquo;s triangle </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Bone cyst with fracture. </span></strong><span style=\"font-size:12.0pt\">Benign bone cysts generally do not cause pain, but if they are large enough, they can weaken the bone and cause it to fracture. This type of fracture is called a <strong>pathologic fracture</strong>. A classic radiographic finding is the&nbsp;fallen fragment sign&nbsp;which occurs when a piece of cortex breaks off after a fracture, and sinks to the gravity-dependent portion of the lesion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture12_A9sYam7.jpg\" style=\"height:297px; width:300px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fallen fragment (leaf) sign</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Fibrosis cystica. Cystic fibrosis&nbsp;</span></strong><span style=\"font-size:12.0pt\">(<strong>CF</strong>), also called&nbsp;<strong>mucoviscidosis,</strong>&nbsp;</span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">is an autosomal recessive genetic disease that affects the exocrine function of the lungs, liver,&nbsp;pancreas,&nbsp;small bowel,&nbsp;sweat glands,&nbsp;and the male genital system.&nbsp;The&nbsp;<strong>musculoskeletal manifestations of cystic fibrosis</strong>&nbsp;are uncommon.&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Musculoskeletal manifestations&nbsp;include low&nbsp;</span><span style=\"font-size:12.0pt\">bone mineral density</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">, short stature, </span><span style=\"font-size:12.0pt\">kyphosis</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">, cystic fibrosis arthropathy (~5%), </span><span style=\"font-size:12.0pt\">hypertrophic osteoarthropathy</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;(~5%), </span><span style=\"font-size:12.0pt\">finger clubbing</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The given image in the question shows a chondromyxoid fibroma of the tibia with </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">lobulated or oval eccentric lytic lesion with well-defined sclerotic margin. </span></span></span></li>\r\n</ul>",
    "correct_choice_id": 1756,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 459,
    "choices": [
      {
        "id": 1832,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chronic osteomyelitis </span></span></span></p>"
      },
      {
        "id": 1833,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Osteosarcoma</span></span></span></p>"
      },
      {
        "id": 1834,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rickets </span></span></span></p>"
      },
      {
        "id": 1835,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hyperparathyroidism</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 12-year-old boy presents with chronic knee pain for 2 years. Knee X-ray is shown below. Probable diagnosis is: </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/08/codman-triangle.jpg\" style=\"height:221px; width:300px\" /></p>",
    "unique_key": "Q4731470",
    "question_audio": null,
    "question_video": null,
    "map_id": 484,
    "difficulty_level": "beginner",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Osteosarcoma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In the given image, <strong>Codman&rsquo;s Triangle</strong> is shown, which is seen in the <strong>osteosarcoma</strong>. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture27.jpg\" style=\"height:220px; width:300px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">OSTEOSARCOMA</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The periosteal reaction may take the form of <strong>&ldquo;Codman&rsquo;s triangle&rdquo;</strong>, or it may have a <strong>&ldquo;sunburst&rdquo; or &ldquo;hair on end&rdquo; appearance</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It occurs when the bone lesion grows aggressively that it lifts the periosteum off the bone and do not allow the periosteum to lay down new bone.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>periosteal reaction is interrupted type</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The central aspect of the lesion does not have any overlying ossification. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Option A. Chronic osteomyelitis.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Homogeneous osteosclerosis and/or sequestrum formation is characteristic of chronic osteomyelitis on radiograph.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture28.jpg\" style=\"height:426px; width:400px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Rickets.&nbsp;</span></strong><span style=\"font-size:12.0pt\">There is growth plate widening and abnormal configuration of the metaphysis, seen as <strong>fraying</strong>&nbsp;(indistinct margins of the metaphysis); <strong>splaying</strong>&nbsp;(widening of metaphyseal ends); <strong>cupping</strong>&nbsp;(concavity of metaphysis) and pseudofracture on the compression side of bone known as <strong>Looser&#39;s zone</strong>. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture29.jpg\" style=\"height:288px; width:600px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Hyperparathyroidism.&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Radiological Features of Hyperparathyroidism are <strong>s</strong></span><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ubperiosteal resorption&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">of terminal tufts of phalanges, lateral end of clavicle and symphysis pubis. There is <strong>loss of lamina dura</strong> of tooth socket surrounding teeth, generalized osteopenia, thinning of cortices, and indistinct bony trabeculae. There is also the presence of <strong>brown tumors</strong> and <strong>salt pepper appearance</strong> of the skull. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture30.jpg\" style=\"height:327px; width:300px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Brown tumors</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture31.jpg\" style=\"height:241px; width:300px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Salt pepper appearance of the skull</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The given x-ray image shows the formation of codman&rsquo;s triangle which is seen in the cases of osteosarcoma. </span></span></span></li>\r\n</ul>",
    "correct_choice_id": 1833,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 461,
    "choices": [
      {
        "id": 1840,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">2nd decade </span></span></span></p>"
      },
      {
        "id": 1841,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">3rd decade</span></span></span></p>"
      },
      {
        "id": 1842,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">5th decade </span></span></span></p>"
      },
      {
        "id": 1843,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">6th decade</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Peak incidence of osteosarcoma occurs at: </span></span></p>",
    "unique_key": "Q5149587",
    "question_audio": null,
    "question_video": null,
    "map_id": 486,
    "difficulty_level": "beginner",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) 2nd decade</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">OSTEOSARCOMA</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Osteosarcoma is a tumor characterized by the <strong>production of osteoid matrix by malignant cells</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is the <strong>second most common primary malignancy of bone behind multiple myeloma</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Onset can occur at any age; however, primary high-grade osteosarcoma occurs most commonly in the second decade of life. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">All skeletal locations can be affected; however, <strong>most primary osteosarcomas</strong> occur at the sites of the most rapid bone growth, including the <strong>distal femur, the proximal tibia, and the proximal humerus</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Secondary osteosarcomas occur at the site of another disease process. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">They rarely occur in young patients, but constitute almost half of the osteosarcomas in patients older than age 50 years.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Primary osteosarcoma is primarily seen in the 2<sup>nd</sup> decade of life whereas the secondary osteosarcoma is seen in patients &gt;50 years of age. </span></span></span></li>\r\n</ul>",
    "correct_choice_id": 1840,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 463,
    "choices": [
      {
        "id": 1848,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Osteosarcoma </span></span></span></p>"
      },
      {
        "id": 1849,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chondrosarcoma</span></span></span></p>"
      },
      {
        "id": 1850,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Ewing&rsquo;s sarcoma </span></span></span></p>"
      },
      {
        "id": 1851,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Osteochondroma</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,&quot;sans-serif&quot;\">22 year old male present with bony mass in the metaphyseal region of right. knee with typical sun ray appearance and CT Scan of the chest reveals osteoblastic metastases. What is the most probable diagnosis?</span></span></p>",
    "unique_key": "Q3151166",
    "question_audio": null,
    "question_video": null,
    "map_id": 488,
    "difficulty_level": "beginner",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Ans. A) Osteosarcoma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">OSTEOSARCOMA</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The periosteal reaction in the osteosarcoma may show as the sunray appearance on the radiograph. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture32.jpg\" style=\"height:325px; width:300px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Sunray appearance</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">CT scan of the chest are done to search for pulmonary metastasis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lungs are the most common sites for metastases. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>most important prognostic factor at the time of diagnosis is the extent of the disease</strong> (staging). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Approximately 15% of patients with osteosarcoma have detectable pulmonary metastases at the time of diagnosis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">As a group, these patients continue to have a poor prognosis with <strong>less than 20% long-term survival.</strong> </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Patients with non-pulmonary metastases (e.g., bone metastases) have an even worse prognosis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Patients with <strong>&ldquo;skip&rdquo; metastases</strong> (i.e., a metastasis within the same bone as the primary tumor or across the joint from the primary tumor) <strong>have the same poor prognosis as patients with distant metastases.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Chondrosarcoma.&nbsp; </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The radiographic appearance of chondrosarcoma shows a lesion arising in the medullary cavity with irregular matrix calcification. The pattern of calcification is described as &ldquo;<strong>punctate</strong>&rdquo;, &ldquo;<strong>popcorn</strong>&rdquo;, or &ldquo;<strong>comma-shaped</strong>&rdquo;. There is bone destruction, cortical erosions, and periosteal reaction. </span><span style=\"font-size:12.0pt\">Chondrosarcoma is a highly malignant tumor with the potent capacity to cause local invasion and distant metastasis, preferentially in the lungs. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture33.jpg\" style=\"height:242px; width:400px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Ewing&rsquo;s sarcoma.&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ewing sarcoma appears radiographically as a <em>destructive lesion in the diaphysis </em>of a long bone with an &ldquo;<strong>onion skin</strong>&rdquo; periosteal reaction. Lung is the most common site of metastases followed by the bone. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture34.jpg\" style=\"height:277px; width:400px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Osteochondroma.&nbsp;</span></strong><span style=\"font-size:12.0pt\">An osteochondroma can be either sessile or pedunculated and is seen in the metaphyseal region typically projecting away from the epiphysis. There is associated broadening of the&nbsp;metaphysis&nbsp;from which it arises. The cartilage cap can be thin and difficult to identify, or thick with&nbsp;rings and arcs calcification&nbsp;and irregular subchondral bone. </span><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The incidence of malignant degeneration&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">is approximately <strong>1% for patients with a solitary osteochondroma and 6% </strong>for patients with <strong>multiple hereditary exostoses</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/picture35.jpg\" style=\"height:278px; width:400px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The given characteristics of bony mass in metaphysis of knee with <strong>sunray appearance</strong> and osteoblastic metastases in chest are seen in the osteosarcoma of the bone. </span></span></span></li>\r\n</ul>",
    "correct_choice_id": 1848,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette"
    ]
  },
  {
    "id": 466,
    "choices": [
      {
        "id": 1860,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ewing&#39;s sarcoma </span></span></span></p>"
      },
      {
        "id": 1861,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Retinoblastoma</span></span></span></p>"
      },
      {
        "id": 1862,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Osteosarcoma</span></span></span></p>"
      },
      {
        "id": 1863,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Neuroblastoma</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following malignant tumors is radio-resistant? </span></span></p>",
    "unique_key": "Q8889184",
    "question_audio": null,
    "question_video": null,
    "map_id": 491,
    "difficulty_level": "beginner",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Ans. C) Osteosarcoma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Radio-Resistant Bone Tumor</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Metastatic renal cell carcinoma </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Liposarcoma</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Synovial cell sarcoma </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Osteosarcoma (most resistant)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Malignant fibrous histiocytoma </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fibrosarcoma of bone</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rhabdomyosarcoma </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chondrosarcoma</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fibrosarcoma</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Malignant GCT</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Ewing&rsquo;s sarcoma</span></strong><span style=\"font-size:12.0pt\">. It is highly radio-sensitive tumor. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Retinoblastoma</span></strong><span style=\"font-size:12.0pt\">. It is also a radio-sensitive tumor. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Neuroblastoma</span></strong><span style=\"font-size:12.0pt\">. It is also a radio-sensitive tumor. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective</span></strong><span style=\"font-size:12.0pt\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Among the given options, <strong>osteosarcoma is a highly radio-resistant tumor</strong>. Thus, it is ideally treated with chemotherapy followed by limb salvage surgery followed by chemotherapy. </span></span></span></li>\r\n</ul>",
    "correct_choice_id": 1862,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 467,
    "choices": [
      {
        "id": 1864,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Giant cell tumor</span></span></span></p>"
      },
      {
        "id": 1865,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ewing&#39;s sarcoma</span></span></span></p>"
      },
      {
        "id": 1866,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Osteogenic sarcoma </span></span></span></p>"
      },
      {
        "id": 1867,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Secondary metastasis</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An 8-year-male child presents with progressive swelling of upper end tibia which is irregular with local temperature raised, variable consistency and ill-defined margins. What is the probable diagnosis? </span></span></p>",
    "unique_key": "Q6703449",
    "question_audio": null,
    "question_video": null,
    "map_id": 492,
    "difficulty_level": "difficult",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Osteogenic sarcoma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The clinical presentation in question can occur <strong>both in Ewing&rsquo;s sarcoma and osteosarcoma:</strong></span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">History of trivial trauma</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Progressive swelling</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Raised local temperature</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Variable consistency</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ill-defined margins</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">However, <strong>swelling is around the knee joint at upper end of tibia, which favours the diagnosis of osteosarcoma</strong> (metaphyseal lesion).</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ewing&rsquo;s sarcoma usually occurs in the diaphysis of the bone (middle of the shaft).</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Giant cell tumor</span></strong><span style=\"font-size:12.0pt\">. This is commonly seen in the <strong>epiphyseal</strong> region of the long bones. The lesion is <strong>solitary</strong>. The swelling is associated with more extensive lesions and a soft tissue mass or bump is occasional. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Ewing&rsquo;s sarcoma</span></strong><span style=\"font-size:12.0pt\">. Ewing&rsquo;s sarcoma presents with <strong>local rise of temperature</strong>, <strong>progressive swelling</strong> with variable consistency and ill-defined margins but it is seen in the <strong>diaphyseal</strong> region of the long bones. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Secondary metastasis</span></strong><span style=\"font-size:12.0pt\">. <strong>Spine</strong> and <strong>pelvis</strong> are the most common sites of secondary metastasis. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective</span></strong><span style=\"font-size:12.0pt\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The given clinical features are seen in both osteosarcoma and Ewing&rsquo;s sarcoma. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The only differentiating point is the involvement of the upper end of the tibia i.e., the metaphysis, which is involved in the osteosarcoma and not ewing&rsquo;s sarcoma.&nbsp; </span></span></span></li>\r\n</ul>",
    "correct_choice_id": 1866,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette"
    ]
  },
  {
    "id": 469,
    "choices": [
      {
        "id": 1872,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MRI of femur </span></span></span></p>"
      },
      {
        "id": 1873,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bone marrow biopsy</span></span></span></p>"
      },
      {
        "id": 1874,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bone scan </span></span></span></p>"
      },
      {
        "id": 1875,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">CT chest</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following investigations are needed for the diagnosis of osteosarcoma, except: </span></span></p>",
    "unique_key": "Q7171979",
    "question_audio": null,
    "question_video": null,
    "map_id": 494,
    "difficulty_level": "difficult",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Bone marrow biopsy</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A <strong>biopsy</strong> of the lesion (not bone marrow biopsy) should always be carried out before commencing treatment.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bone scan, MRI and CT chest are used.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. MRI of femur</span></strong><span style=\"font-size:12.0pt\">. </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MRI is the best test to measure the <strong>extent of the tumor</strong> within the bone and in the soft tissue and to determine the relationship of the tumor to nearby anatomical structures.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Bone scan</span></strong><span style=\"font-size:12.0pt\">. </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A bone scan should be obtained to look for <strong>skeletal metastases</strong>.<strong> </strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. CT chest.&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CT scans of the chest should be done to search for <strong>pulmonary metastases</strong>.<strong> </strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">All the given investigations are done in a case of osteosarcoma except for the bone marrow biopsy. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Instead, biopsy of the lesion if done before starting the treatment. </span></span></span></li>\r\n</ul>",
    "correct_choice_id": 1873,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "InvestigationBased"
    ]
  },
  {
    "id": 470,
    "choices": [
      {
        "id": 1876,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Osteosarcoma</span></span></span></p>"
      },
      {
        "id": 1877,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Ewing&#39;s sarcoma</span></span></span></p>"
      },
      {
        "id": 1878,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Osteoclastoma</span></span></span></p>"
      },
      {
        "id": 1879,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Chondroblastoma</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following bone tumor present with secondaries in lung with pneumothorax: </span></span></p>",
    "unique_key": "Q6835971",
    "question_audio": null,
    "question_video": null,
    "map_id": 495,
    "difficulty_level": "beginner",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Ans. A) Osteosarcoma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Both osteogenic sarcoma and Ewing&#39;s sarcoma may have metastasis to lung.</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">However, it is <strong>much more common in osteogenic sarcoma</strong> and about 10% of patients have pulmonary metastasis by the time they are first seen. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Incidence of pneumothorax is higher in osteosarcoma metastasis.</span></strong></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Ewing&rsquo;s sarcoma</span></strong><span style=\"font-size:12.0pt\">. This tumor also metastasize to lung but osteosarcoma metastasis is more common. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Osteoclastoma</span></strong><span style=\"font-size:12.0pt\">. It rarely metastasize to lung. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Chondroblastoma</span></strong><span style=\"font-size:12.0pt\">. This tumor also metastasize to lung but osteosarcoma metastasis is more common. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective</span></strong><span style=\"font-size:12.0pt\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Osteosarcoma is the most common tumor that metastasize to the lungs with increased incidence of pneumothorax. </span></span></span></li>\r\n</ul>",
    "correct_choice_id": 1876,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 479,
    "choices": [
      {
        "id": 1912,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"DE\" style=\"font-size:12.0pt\">t(2;8) </span></span></span></p>"
      },
      {
        "id": 1913,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"DE\" style=\"font-size:12.0pt\">t (11;22)</span></span></span></p>"
      },
      {
        "id": 1914,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"DE\" style=\"font-size:12.0pt\">t (x;18) </span></span></span></p>"
      },
      {
        "id": 1915,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"DE\" style=\"font-size:12.0pt\">t (14;18)</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Characteristic translocation seen in Ewing&rsquo;s sarcoma is: </span></span></p>",
    "unique_key": "Q5627812",
    "question_audio": null,
    "question_video": null,
    "map_id": 504,
    "difficulty_level": "beginner",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"DE\" style=\"font-size:12.0pt\">Ans. B) t (11;22)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"DE\" style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ewing&#39;s sarcoma is part of a family of <strong>peripheral neuroectodermal tumors (PNET) </strong>that share a common cytogenetic <strong>translocation of chromosomes 11 and 22, t(11:22.)</strong>, differing only in their degree of neural differentiation. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ewing&rsquo;s sarcoma is poorly differentiated whereas PNET exhibits definite neural differentiation (N myc positive).</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>t(11; 22) (q24; q12)</strong> is the most common translocation diagnostic of Ewing sarcoma and is present in greater than 90% of cases. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Other diagnostic translocations includes <strong>t(21; 22) (q22; q12), t(7; 22) (p22; q12), trisomy 8 and trisomy 12</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">MIC2(CD99) is a specific marker</span></strong><span style=\"font-size:12.0pt\"> for Ewing&#39;s sarcoma and peripheral primitive neuroectodermal tumors and is expressed on short-arm of chromosome x and y. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. t(2;8).&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is seen in <strong>Burkitt&rsquo;s lymphoma</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. t(x;18).&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is seen in <strong>synovial sarcoma</strong>. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. t(14;18).&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is seen in <strong>follicular lymphoma</strong>. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">t(11;22) translocation is characteristic of Ewing&rsquo;s sarcoma. </span></span></span></li>\r\n</ul>",
    "correct_choice_id": 1913,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 481,
    "choices": [
      {
        "id": 1920,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Ewing&#39;s sarcoma </span></span></span></p>"
      },
      {
        "id": 1921,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Osteosarcoma</span></span></span></p>"
      },
      {
        "id": 1922,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Multiple myeloma</span></span></span></p>"
      },
      {
        "id": 1923,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Metastasis</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In 1st decade of life, the most common bone tumor is: </span></span></p>",
    "unique_key": "Q4814295",
    "question_audio": null,
    "question_video": null,
    "map_id": 506,
    "difficulty_level": "beginner",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Ewing&#39;s sarcoma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">EWING SARCOMA</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ewing sarcoma is the <strong>fourth most common primary malignancy of bone</strong>, but it is the second most common (after osteosarcoma) in patients younger than 30 years of age and the <strong>most common in patients younger than 10 years of age</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Its maximum incidence is seen in 2nd decade of life.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Osteosarcoma.&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is commonly seen in <strong>2<sup>nd</sup> decade</strong> of life. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Multiple myeloma.&nbsp;&nbsp;</span></strong><span style=\"font-size:12.0pt\">ts incidence peaks in <strong>5<sup>th</sup>-7<sup>th</sup> decade</strong> of life. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Metastasis.&nbsp;</span></strong><span style=\"font-size:12.0pt\">It occurs in patients <strong>&gt;40</strong> years of age. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ewing&rsquo;s sarcoma is common in 1<sup>st</sup> decade of life, in children younger than 10 years of age.</span></span></span></li>\r\n</ul>",
    "correct_choice_id": 1920,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 482,
    "choices": [
      {
        "id": 1924,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Ewing&#39;s sarcoma </span></span></span></p>"
      },
      {
        "id": 1925,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Osteosarcoma</span></span></span></p>"
      },
      {
        "id": 1926,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Chondrosarcoma</span></span></span></p>"
      },
      {
        "id": 1927,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Multiple myeloma</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PAS positive cells are seen in: </span></span></p>",
    "unique_key": "Q6232595",
    "question_audio": null,
    "question_video": null,
    "map_id": 507,
    "difficulty_level": "intermediate",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Ewing&#39;s sarcoma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ewing sarcomas usually are <strong>periodic acid&ndash;Schiff (PAS) positive</strong> (owing to intracellular glycogen) and <strong>reticulin negative</strong>. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Osteosarcoma</span></strong><span style=\"font-size:12.0pt\">. About <strong>27%</strong> of osteosarcomas have PAS positive cells.&nbsp; </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Chondrosarcoma</span></strong><span style=\"font-size:12.0pt\">. About <strong>92%</strong> of chondrosarcomas have PAS positive cells. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Multiple myeloma</span></strong><span style=\"font-size:12.0pt\">. Multiple myelomas have <strong>PAS negative</strong> cells. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective</span></strong><span style=\"font-size:12.0pt\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">All ewing sarcomas have PAS positive cells among the given options.</span></span></span></li>\r\n</ul>",
    "correct_choice_id": 1924,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 484,
    "choices": [
      {
        "id": 1932,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Ewing&#39;s sarcoma </span></span></span></p>"
      },
      {
        "id": 1933,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Osteosarcoma</span></span></span></p>"
      },
      {
        "id": 1934,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Chondrosarcoma</span></span></span></p>"
      },
      {
        "id": 1935,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Multiple myeloma</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mic 2 positive cells are seen in: </span></span></p>",
    "unique_key": "Q6008048",
    "question_audio": null,
    "question_video": null,
    "map_id": 509,
    "difficulty_level": "beginner",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Ewing&#39;s sarcoma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Mic 2 (CD99) is a specific marker for Ewing&#39;s sarcoma</span></strong><span style=\"font-size:12.0pt\"> and peripheral primitive neuroectodermal tumors and is expressed on short-arm of chromosome x and y. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In addition, Ewing sarcomas usually are <strong>periodic acid&ndash;Schiff positive</strong> (owing to intracellular glycogen) and <strong>reticulin negative</strong>. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Osteosarcoma, Option C. Chondrosarcoma, and Option D. Multiple myeloma</span></strong><span style=\"font-size:12.0pt\"> are negative for MIC 2 cells.&nbsp; </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MIC2 is a specific marker for Ewing&rsquo;s sarcoma. </span></span></span></li>\r\n</ul>",
    "correct_choice_id": 1932,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 485,
    "choices": [
      {
        "id": 1936,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Dermatofibrosarcoma protuberans</span></span></span></p>"
      },
      {
        "id": 1937,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Ewing&#39;s sarcoma</span></span></span></p>"
      },
      {
        "id": 1938,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Osteosarcoma</span></span></span></p>"
      },
      {
        "id": 1939,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Metastasis</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CD 99 is marker of: </span></span></p>",
    "unique_key": "Q2147014",
    "question_audio": null,
    "question_video": null,
    "map_id": 510,
    "difficulty_level": "beginner",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Ans. B) Ewing&#39;s sarcoma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Mic 2 (CD99) is a specific marker for Ewing&#39;s sarcoma</span></strong><span style=\"font-size:12.0pt\"> and peripheral primitive neuroectodermal tumors and is expressed on short-arm of chromosome x and y. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In addition, Ewing sarcomas usually are <strong>periodic acid&ndash;Schiff positive</strong> (owing to intracellular glycogen) and <strong>reticulin negative</strong>. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Dermatofibrosarcoma protuberans. CD 34&nbsp;</span></strong><span style=\"font-size:12.0pt\">is the most consistent marker for DFSP.<strong> </strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Osteosarcoma. RBM 15&nbsp;</span></strong><span style=\"font-size:12.0pt\">and <strong>YTHDC1</strong> are the specific markers for osteosarcoma.<strong> </strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Metastasis.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Bone metastases tumor biomarkers include bone specific alkaline phosphatase (<strong>BALP</strong>), tartrate-resistant acid phosphatase (<strong>TRACP</strong>), tumor necrosis factor (<strong>TNF</strong>), carbohydrate antigen 15-3 (<strong>CA15-3</strong>).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">CD 99 is the specific marker for Ewing&rsquo;s sarcoma. </span></span></span></li>\r\n</ul>",
    "correct_choice_id": 1937,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 486,
    "choices": [
      {
        "id": 1940,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">CRP measurement </span></span></span></p>"
      },
      {
        "id": 1941,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Core biopsy</span></span></span></p>"
      },
      {
        "id": 1942,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tc99 MDP scan </span></span></span></p>"
      },
      {
        "id": 1943,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MRI</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 7-year-old boy with h/o trauma 2 months back now presents with fever and acute pain over thigh. On X-ray, femoral shaft shows lesions with multiple laminated periosteal reaction. Next line of management is: </span></span></p>",
    "unique_key": "Q2289208",
    "question_audio": null,
    "question_video": null,
    "map_id": 511,
    "difficulty_level": "intermediate",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) MRI</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Information in this question are:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1st Decade</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Diaphyseal&nbsp;</span></strong><span style=\"font-size:12.0pt\">lesion with <strong>onion peel</strong> reaction goes towards Ewing&rsquo;s sarcoma. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Next best investigation is MRI for soft tissue involvement, marrow involvement and micro metastasis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Overall, the best investigation is Biopsy&nbsp;</span></strong><span style=\"font-size:12.0pt\">to confirm the diagnosis but MRI is done before the biopsy, to localize the best site for biopsy.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. CRP measurement</span></strong><span style=\"font-size:12.0pt\">. In Ewing&#39;s sarcoma cases, <strong>CRP pre-treatment value&nbsp;&gt;0.5 mg/dL</strong>&nbsp;is considered as a sensitive prognostic risk factor indication for distant metastasis and poor prognosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Core biopsy</span></strong><span style=\"font-size:12.0pt\">. Core biopsy methods are preferable to provide a histological diagnosis of the tumor cell. In some cases, repeated core biopsy attempts may fail to provide a definite result. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Tc99 MDP scan</span></strong><span style=\"font-size:12.0pt\">. When Ewing Sarcoma is lytic, MDP bone scan does not add to staging performed by FDG PET/CT; thus, MDP bone scanning may be omitted. However, when Ewing Sarcoma is sclerotic, MDP bone scan may detect osseous metastases not detected by FDG PET/CT.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective</span></strong><span style=\"font-size:12.0pt\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MRI is the investigation of choice in ewing&rsquo;s sarcoma before biopsy is performed. </span></span></span></li>\r\n</ul>",
    "correct_choice_id": 1943,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 487,
    "choices": [
      {
        "id": 1944,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Sacrum</span></span></span></p>"
      },
      {
        "id": 1945,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Femur</span></span></span></p>"
      },
      {
        "id": 1946,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Ribs</span></span></span></p>"
      },
      {
        "id": 1947,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Proximal tibia</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Commonest site of occurrence of chordoma is: </span></span></p>",
    "unique_key": "Q4587654",
    "question_audio": null,
    "question_video": null,
    "map_id": 512,
    "difficulty_level": "intermediate",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Sacrum</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chordoma is a rare malignant neoplasm that arises from notochord remnants. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chordoma is the <strong>second most common primary malignancy in the spine</strong> (behind myeloma) and is the <strong>most common primary malignancy of the sacrum</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Greater than 50% of chordomas arise in the sacrococcygeal area, and more than 30% arise at the base of the skull. The remainder are dispersed throughout the rest of the spine.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/08/chordoma.jpg\" style=\"height:311px; width:400px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Chordoma (Sacrum) &amp; Physaliferous cells (Cells with small nuclei and vacuoles in cytoplasm)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Femur</span></strong><span style=\"font-size:12.0pt\">. Metaphysis of the femur is most commonly involved in <strong>osteosarcoma</strong>. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Ribs</span></strong><span style=\"font-size:12.0pt\">. <strong>Enchondroma</strong> is the most comon benign rib lesion after fibrous dysplasia. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Proximal tibia</span></strong><span style=\"font-size:12.0pt\">. It is also involved in <strong>osteosarcoma</strong>. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sacrum is most commonly involved in the chordoma.</span></span></span></li>\r\n</ul>",
    "correct_choice_id": 1944,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 488,
    "choices": [
      {
        "id": 1948,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Ewing&#39;s sarcoma </span></span></span></p>"
      },
      {
        "id": 1949,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Osteosarcoma</span></span></span></p>"
      },
      {
        "id": 1950,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Multiple myeloma</span></span></span></p>"
      },
      {
        "id": 1951,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Chondrosarcoma</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following tumor is associated with hyperglycemia? </span></span></p>",
    "unique_key": "Q9125062",
    "question_audio": null,
    "question_video": null,
    "map_id": 513,
    "difficulty_level": "intermediate",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Chondrosarcoma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chondrosarcoma can produce hyperglycemia in 85% cases</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hyperglycemia occurs as a paraneoplastic syndrome. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">There is no association of the tumor with hyperglycemia seen in cases of<strong> ewing&rsquo;s sarcoma (option A), osteosarcoma (option B) </strong>and<strong> multiple myeloma (option D). </strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chondrosarcoma can cause hyperglycemia in around 85% cases. </span></span></span></li>\r\n</ul>",
    "correct_choice_id": 1951,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 497,
    "choices": [
      {
        "id": 1984,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Skull</span></span></span></p>"
      },
      {
        "id": 1985,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pelvis</span></span></span></p>"
      },
      {
        "id": 1986,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vertebrae</span></span></span></p>"
      },
      {
        "id": 1987,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,&quot;sans-serif&quot;\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Small bones of the hand</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metastases is least common in: </span></span></p>",
    "unique_key": "Q6224746",
    "question_audio": null,
    "question_video": null,
    "map_id": 522,
    "difficulty_level": "beginner",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Small bones of the hand</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>commonest site for bone metastases are the VERTEBRAE.</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Extremities distal to elbow and knee are least commonly involved sites.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Skull, pelvis and vertebrae are involved commonly in bone metastasis while the distal extremity bones are least commonly involved. </span></span></span></li>\r\n</ul>",
    "correct_choice_id": 1987,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  }
];
        let quizName = 'Orthopedics Oncology';
        let hierarchy = ["Cerebellum", "qBank", "Orthopedics"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - QuizMaster Pro';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        const urlParams = new URLSearchParams(window.location.search);
        currentQuestionIndex = Math.min(parseInt(urlParams.get('startAt')) || 0, questionsData.length - 1);

        function goBack() {
            if (isQuizCompleted || confirm('Are you sure you want to leave the quiz? Your progress will be lost.')) {
                window.history.back();
            }
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                setTimeout(processAnswer, 300);
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            setTimeout(showSolution, 1500);
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (!window.location.pathname.endsWith('custom_quiz.html')) {
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>